I just learned I have prediabetes. It is estimated that at least 40 million people over the age of 18 are living with diabetes in the United States. Another 100 million people in the U.S. share your ...

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three years later.

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

The phase 1 trial results, published Feb. 19 in Nature, evaluated the personalized mRNA neoantigen vaccine autogene cevumeran in combination with surgery, immunotherapy drug atezolizumab and ...

Scientists have developed a new mRNA vaccine to treat pancreatic cancer that may extend patients' lifespans by 8 to 10 years.

Discover why pancreatic cancer's warning signs often go unnoticed, masquerading as everyday health issues, learn the crucial red flags that shouldn't be ignored ...

A personalized mRNA vaccine may reduce the risks of pancreatic cancer returning after surgery, according to a preliminary ...

There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...